Nearly 40 years after HIV was first identified, the virus continues its devastating march across the globe. Today, 38 million people live with HIV, and each year brings 1.5 million new infections and ...

Sanjay Raut, a senior leader of Shiv Sena, announced he will withdraw from public life for two months due to serious health ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Gilead stock reversed higher on smaller losses early Friday as analysts noted encouraging indicators for its newly approved ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

HOOKIPA Pharma Inc. (OTCID: HOOK, 'HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program and certain of its assets related to HOOKIPA’s HB-500 program ...

Dzidzai is one of 25 Community Adolescent Treatment Supporters (CATS) trained by the National Aids Council (NAC) and the ...

The NHS has secured a confidential discount on the treatment, which is listed at around £7,000 per patient per year, from its ...

The truth is, the existence of Community Health Workers (CHWs) like Muhammad Fitri remains largely unknown to the public. They work with people at the margins of society — many living with HIV/AIDS in ...

Richard says it took two days for a qualified interpreter to arrive and explain he had been given the all-clear. "If an ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...